aGvHD is a major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. The patients (N=173) treated in EAP previously failed 1 to 6 aGvHD systemic treatment ...

Caitlin Chin, Fellow with the Strategic Technologies Program, provided a written statement for a House Judiciary Committee hearing on the U.S. government’s access to personal data. Chairman Nadler, ...

Structure Therapeutics recently reported positive topline Phase 2b and related ACCESS program data for its oral GLP-1 agonist aleniglipron in adults with obesity or overweight, showing clinically ...

As was revealed a week ago in a Tesla app decompiling, the EV maker re-launched its Early Access Program. The program is specifically focused on testing Full Self-Driving builds, and so far, invites ...